Mizuho Maintains Outperform on Harmony Biosciences Hldgs, Raises Price Target to $51
Harmony Biosciences: WAKIX Cash Flow Funds Its Own Disruption
HC Wainwright & Co. Reiterates Buy on Harmony Biosciences Hldgs, Maintains $55 Price Target
Harmony Biosciences Reports Preliminary Q2 WAKIX Sales Of ~$261M, Up 30% YoY; Appoints Stephen Mollichella As Interim CFO
Harmony Biosciences Hldgs Affirms Prelim FY2026 Sales Guidance of $1.000B-$1.040B vs $1.014B Est
Wall Street Analysts See a 27.35% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High?
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
Harmony Biosciences Holdings (NASDAQ:HRMY): A Value Stock with Strong Financial Health
Deutsche Bank Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $36
Harmony Biosciences (HRMY) Stock Valuation After New Pitolisant Data And Reaffirmed Guidance
Is Harmony Biosciences Holdings, Inc. (HRMY) A Good Stock To Buy Now?
Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting
Harmony Biosciences Holdings, Inc. (HRMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Harmony Biosciences Holdings (HRMY): One of the Best Stocks to Buy According to AI
Harmony Biosciences to Participate in Upcoming Investor Conferences
Investors Can Find Comfort In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings Quality
Harmony Biosciences Holdings, Inc. 2026 Q1 - Results - Earnings Call Presentation
Harmony Biosciences Holdings (HRMY) Announces Financial Results for Q1 2026
Earnings Miss: Harmony Biosciences Holdings, Inc. Missed EPS By 21% And Analysts Are Revising Their Forecasts
Harmony Biosciences Holdings (HRMY) Valuation After Q1 2026 Earnings Miss And Profitability Concerns
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.